Scott B. Ullem Edwards Lifesciences Corp (EW) insider trading activity

Scott B. Ullem is CVP, Chief Financial Officer of Edwards Lifesciences Corp. Currently has a direct ownership of 30,561 shares of EW, which is worth approximately $2.3 Million. The most recent transaction as insider was on Dec 09, 2024, when has been sold 11,250 shares (Common Stock) at a price of $71.68 per share, resulting in proceeds of $806,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 30.6K

0% 3M change

58.77% 12M change

Total Value Held $2.3 Million

Scott B. Ullem Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 09 2024	SELL Open market or private sale	$806,400 $71.68 p/Share	11,250 Reduced 26.91%	30,561 Common Stock
Dec 09 2024	BUY Exercise of conversion of derivative security	$509,400 $45.28 p/Share	11,250 Added 21.2%	41,811 Common Stock
Jun 20 2024	SELL Open market or private sale	$493,818 $87.79 p/Share	5,625 Reduced 15.54%	30,561 Common Stock
Jun 20 2024	BUY Exercise of conversion of derivative security	$254,700 $45.28 p/Share	5,625 Added 13.45%	36,186 Common Stock
May 21 2024	SELL Open market or private sale	$508,781 $90.45 p/Share	5,625 Reduced 15.54%	30,561 Common Stock
May 21 2024	BUY Exercise of conversion of derivative security	$254,700 $45.28 p/Share	5,625 Added 13.45%	36,186 Common Stock
May 11 2024	SELL Payment of exercise price or tax liability	$103,890 $86.72 p/Share	1,198 Reduced 3.77%	30,561 Common Stock
May 07 2024	SELL Payment of exercise price or tax liability	$67,221 $85.09 p/Share	790 Reduced 2.43%	31,759 Common Stock
May 07 2024	BUY Grant, award, or other acquisition	-	11,075 Added 25.39%	32,549 Common Stock
May 04 2024	SELL Payment of exercise price or tax liability	$377,742 $85.25 p/Share	4,431 Reduced 17.1%	21,474 Common Stock
May 04 2024	BUY Exercise of conversion of derivative security	-	7,465 Added 22.37%	25,905 Common Stock
May 03 2024	SELL Payment of exercise price or tax liability	$53,928 $85.06 p/Share	634 Reduced 3.32%	18,440 Common Stock
Apr 30 2024	SELL Open market or private sale	$624,007 $86.07 p/Share	7,250 Reduced 27.54%	19,074 Common Stock
Apr 30 2024	BUY Exercise of conversion of derivative security	$266,437 $36.75 p/Share	7,250 Added 21.59%	26,324 Common Stock
Apr 01 2024	SELL Open market or private sale	$690,385 $95.16 p/Share	7,255 Reduced 27.56%	19,074 Common Stock
Apr 01 2024	BUY Exercise of conversion of derivative security	$266,621 $36.75 p/Share	7,255 Added 21.6%	26,329 Common Stock
Feb 29 2024	SELL Open market or private sale	$620,955 $85.59 p/Share	7,255 Reduced 27.56%	19,074 Common Stock
Feb 29 2024	BUY Exercise of conversion of derivative security	$266,621 $36.75 p/Share	7,255 Added 21.6%	26,329 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$14,970 $86.04 p/Share	174 Reduced 0.9%	19,074 Common Stock
Feb 01 2024	SELL Open market or private sale	$567,993 $78.29 p/Share	7,255 Reduced 27.37%	19,248 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	$266,621 $36.75 p/Share	7,255 Added 21.49%	26,503 Common Stock
Dec 29 2023	SELL Open market or private sale	$1,110,740 $76.55 p/Share	14,510 Reduced 42.98%	19,248 Common Stock
Dec 29 2023	BUY Exercise of conversion of derivative security	$533,242 $36.75 p/Share	14,510 Added 30.06%	33,758 Common Stock
Oct 31 2023	SELL Open market or private sale	$454,598 $62.66 p/Share	7,255 Reduced 27.37%	19,248 Common Stock
Oct 31 2023	BUY Exercise of conversion of derivative security	$266,621 $36.75 p/Share	7,255 Added 21.49%	26,503 Common Stock

Also insider at

BERY

BERRY GLOBAL GROUP, INC. Consumer Cyclical

ILMN

ILLUMINA, INC. Healthcare

Director

SBU

Scott B. Ullem

CVP, Chief Financial Officer

Irvine, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EW shares.

Notify only if

Value

Insider Trading

Get notified when an Edwards Lifesciences Corp insider buys or sells EW shares.

Notify only if

Operation

Value

Type

News

Receive news related to Edwards Lifesciences Corp

Track Activities on EW

Account